The Scientist

» nanoparticle and immunology

Most Recent

image: Enhancing Vaccine Development

Enhancing Vaccine Development

By | June 1, 2016

Using proteomics methods to inform antigen selection

1 Comment

Member, Department of Immunology, St. Jude Children’s Research Hospital. Age: 43

0 Comments

image: Toward Targeted Therapies for Autoimmune Disorders

Toward Targeted Therapies for Autoimmune Disorders

By | June 1, 2016

Training the immune system to cease fire on native tissues could improve outcomes for autoimmune patients, but clinical progress has been slow.

1 Comment

image: FDA Approves Bladder Cancer Immunotherapy

FDA Approves Bladder Cancer Immunotherapy

By | May 23, 2016

The US Food and Drug Administration greenlights Roche’s Tecentriq, which blocks a protein that obstructs the immune system’s ability to fight cancer.

0 Comments

Certain drugs could worsen graft-versus-host disease in stem cell transplant patients, scientists show.

1 Comment

image: Tasmanian Devil Antibodies Fight Cancer

Tasmanian Devil Antibodies Fight Cancer

By | May 9, 2016

The proteins could be the key to stopping the transmissible facial tumor disease that is threatening the species.

0 Comments

image: Breast Milk Primes Gut for Microbes

Breast Milk Primes Gut for Microbes

By | May 5, 2016

Maternal antibodies engender a receptive gut environment for beneficial bacteria in newborn mice.

2 Comments

image: Copper Stopper

Copper Stopper

By | May 1, 2016

This research found that coating hospital surfaces with copper helped battle microbes and the infections they spread.

1 Comment

image: Nanoscale Defenses

Nanoscale Defenses

By | May 1, 2016

Coating hospital surfaces, surgical equipment, patient implants, and water-delivery systems with nanoscale patterns and particles could curb the rise of hospital-acquired infections.

2 Comments

image: Study: “Dirty” Mice More Humanlike

Study: “Dirty” Mice More Humanlike

By | April 21, 2016

Housing laboratory mice with those reared in a pet store makes the lab rodents’ immune systems more similar to those of people.

2 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham